Market capitalization | $2.34m |
Enterprise Value | $-710.00k |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 0.05 |
EV/Sales (TTM) EV/Sales | -0.10 |
P/S ratio (TTM) P/S ratio | 0.31 |
P/B ratio (TTM) P/B ratio | 0.25 |
Revenue growth (TTM) Revenue growth | -9.20% |
Revenue (TTM) Revenue | $7.43m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
1 Analyst has issued a forecast Avinger, Inc.:
1 Analyst has issued a forecast Avinger, Inc.:
Jun '24 |
+/-
%
|
||
Revenue | 7.43 7.43 |
9%
9%
|
|
Gross Profit | 1.48 1.48 |
45%
45%
|
|
EBITDA | -16 -16 |
17%
17%
|
EBIT (Operating Income) EBIT | -18 -18 |
15%
15%
|
Net Profit | -19 -19 |
13%
13%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Avinger, Inc. manufactures catheter devices used to treat vascular diseases. It designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. The company offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.
Head office | United States |
CEO | Jeffrey Soinski |
Employees | 72 |
Founded | 2007 |
Website | www.avinger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.